Two Faces of Regulatory T Cells: From Immune Defense to Tumoral Progression

References (72)

1. 1 The immune contexture in human tumours: impact on clinical outcome [DOI]
2. 2 Nivolumab plus Ipilimumab in Advanced Melanoma [DOI]
3. 3 Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy [DOI]
4. 4 PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma [DOI]
5. 5 Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse [DOI]
6. 6 A clonogenic common myeloid progenitor that gives rise to all myeloid lineages [DOI]
7. 7 Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression [DOI]
8. 8 Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters [DOI]
9. 9 The inhibitory cytokine IL-35 contributes to regulatory T-cell function [DOI]
10. 10 Cell Contact–Dependent Immunosuppression by Cd4+Cd25+Regulatory T Cells Is Mediated by Cell Surface–Bound Transforming Growth Factor β [DOI]
11. 11 Induction of Tumor Immunity by Removing CD25+CD4+ T Cells: A Common Basis Between Tumor Immunity and Autoimmunity [DOI]
12. 12 Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma [DOI]
13. 13 Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis [DOI]
14. 14 Interleukin-10 Signaling in Regulatory T Cells Is Required for Suppression of Th17 Cell-Mediated Inflammation [DOI]
15. 15 Cutting Edge: Contact-Mediated Suppression by CD4+CD25+ Regulatory Cells Involves a Granzyme B-Dependent, Perforin-Independent Mechanism [DOI]
16. 16 JM2, encoding a fork head–related protein, is mutated in X-linked autoimmunity–allergic disregulation syndrome [DOI]
17. 17 Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells [DOI]
18. 18 A dominant function for interleukin 27 in generating interleukin 10–producing anti-inflammatory T cells [DOI]
19. 19 Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells [DOI]
20. 20 Regulatory T Cells Recruited through CCL22/CCR4 Are Selectively Activated in Lymphoid Infiltrates Surrounding Primary Breast Tumors and Lead to an Adverse Clinical Outcome [DOI]
21. 21 Journey through the thymus: stromal guides for T-cell development and selection [DOI]
22. 22 Foxp3 + natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation [DOI]
23. 23 A Key Role of Leptin in the Control of Regulatory T Cell Proliferation [DOI]
24. 24 Regulatory T cells: recommendations to simplify the nomenclature [DOI]
25. 25 Regulatory T Cells Inhibit Dendritic Cells by Lymphocyte Activation Gene-3 Engagement of MHC Class II [DOI]
26. 26 Scurfin (FOXP3) Acts as a Repressor of Transcription and Regulates T Cell Activation [DOI]
27. 27 Thymopoiesis independent of common lymphoid progenitors [DOI]
28. 28 Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells [DOI]
29. 29 Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo [DOI]
30. 30 Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting [DOI]
31. 31 Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia [DOI]
32. 32 Zoned Out: Functional Mapping of Stromal Signaling Microenvironments in the Thymus [DOI]
33. 33 The development and immunosuppressive functions of CD4+ CD25+ FoxP3+ regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway [DOI]
34. 34 Visceral Adipose Inflammation in Obesity Is Associated with Critical Alterations in Tregulatory Cell Numbers [DOI]
35. 35 Classical dendritic cells are required for dietary antigen–mediated induction of peripheral Treg cells and tolerance [DOI]
36. 36 Phase II Study of the Anti-Cytotoxic T-Lymphocyte–Associated Antigen 4 Monoclonal Antibody, Tremelimumab, in Patients With Refractory Metastatic Colorectal Cancer [DOI]
37. 37 IL-10 Potentiates Differentiation of Human Induced Regulatory T Cells via STAT3 and Foxo1 [DOI]
38. 38 Mechanisms of T Cell Development and Transformation [DOI]
39. 39 Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance [DOI]
40. 40 Signaling Through OX40 Enhances Antitumor Immunity [DOI]
41. 41 Regulatory T Cells Interfere with Glutathione Metabolism in Dendritic Cells and T Cells [DOI]
42. 42 Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines [DOI]
43. 43 Characterization of TCR Gene Rearrangements During Adult Murine T Cell Development [DOI]
44. 44 Quiescence of Memory CD8+ T Cells Is Mediated by Regulatory T Cells through Inhibitory Receptor CTLA-4 [DOI]
45. 45 Cutting Edge: Fasting-Induced Hypoleptinemia Expands Functional Regulatory T Cells in Systemic Lupus Erythematosus [DOI]
46. 46 Regulatory T-Cell-Mediated Suppression of Conventional T-Cells and Dendritic Cells by Different cAMP Intracellular Pathways [DOI]
47. 47 Accumulation of CCR4+ CTLA-4hi FOXP3+CD25hi Regulatory T Cells in Colon Adenocarcinomas Correlate to Reduced Activation of Conventional T Cells [DOI]
48. 48 Human Regulatory T Cells Mediate Transcriptional Modulation of Dendritic Cell Function [DOI]
49. 49 TCR gene recombination and alpha beta-gamma delta lineage divergence: productive TCR-beta rearrangement is neither exclusive nor preclusive of gamma delta cell development [DOI]
50. 50 T cell- but not tumor cell-produced TGF-β1 promotes the development of spontaneous mammary cancer [DOI]
51. 51 Targeting Treg cells in cancer immunotherapy [DOI]
52. 52 Stability and function of regulatory T cells expressing the transcription factor T-bet [DOI]
53. 53 FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets [DOI]
54. 54 Obesity and Breast Cancer: Role of Leptin [DOI]
55. 55 Regulatory T Cells: the Many Faces of Foxp3 [DOI]
56. 56 Cancer immunotherapy via targeted TGF-β signalling blockade in TH cells [DOI]
57. 57 Rational design of anti-GITR-based combination immunotherapy [DOI]
58. 58 Tumor-infiltrating human CD4 + regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivity [DOI]
59. 59 Reciprocal Expression of IL-35 and IL-10 Defines Two Distinct Effector Treg Subsets that Are Required for Maintenance of Immune Tolerance [DOI]
60. 60 Regulatory T Cells in Tumor Microenvironment and Approach for Anticancer Immunotherapy [DOI]
61. 61 Fasting selectively blocks development of acute lymphoblastic leukemia via leptin-receptor upregulation [DOI]
62. 62 Cancer immunotherapy by targeting immune checkpoints: mechanism of T cell dysfunction in cancer immunity and new therapeutic targets [DOI]
63. 63 Mechanisms of human FoxP3+ Treg cell development and function in health and disease [DOI]
64. 64 Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells [DOI]
65. 65 A Unique Population: Adipose-Resident Regulatory T Cells [DOI]
66. 66 PD‐1 inhibitors for non‐small cell lung cancer patients with special issues: Real‐world evidence [DOI]
67. 67 Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo [DOI]
68. 68 Neoadjuvant Immunotherapy for Locally Advanced Melanoma [DOI]
69. 69 BMI and outcomes in melanoma: more evidence for the obesity paradox [DOI]
70. 70 Obesity and Immunotherapy: The Surprisingly Positive Association! [DOI]
71. 71 Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia [DOI]
72. 72 Rational design of anti-GITR-based combination immunotherapy [DOI]

Cited by 0

No indexed citations yet.

Related research

• Pulmonary Arterial Hypertension and Cancer: An Update on Their Similarities — shares topic coverage
• A Survey of Environmental Radioactivity Levels in Science Laboratories of Abuja Campus University of Port- Harcourt, Nigeria — shares topic coverage
• A Multimodal Strategic Approach to Integrative Oncology — shares topic coverage
• Stomach Cancer and Parabens — shares topic coverage
• Traditional, Medicinal and Nutraceutical Values of Minor Fruit: Longan — shares topic coverage